[
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade",
    "summary": "In the most recent trading session, Johnson & Johnson (JNJ) closed at $150.47, indicating a -1.24% shift from the previous trading day.",
    "url": "https://finnhub.io/api/news?id=fd55e46e50ca17b03adc0c64ead8c6fdf6b64695551335404ac193049dc6f66e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733352304,
      "headline": "Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade",
      "id": 131772531,
      "image": "https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "In the most recent trading session, Johnson & Johnson (JNJ) closed at $150.47, indicating a -1.24% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=fd55e46e50ca17b03adc0c64ead8c6fdf6b64695551335404ac193049dc6f66e"
    }
  },
  {
    "ts": null,
    "headline": "Columbia Dividend Income Fund Q3 2024 Commentary",
    "summary": "Institutional Class shares of Columbia Dividend Income Fund returned 8.12% for the \nquarter ending September 30, 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=00f44478a7c2c5c5bdfac13b4f48e8cf05839cda2b4c30419cf2a53e60304be9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733351400,
      "headline": "Columbia Dividend Income Fund Q3 2024 Commentary",
      "id": 131773107,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1365758819/image_1365758819.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Institutional Class shares of Columbia Dividend Income Fund returned 8.12% for the \nquarter ending September 30, 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=00f44478a7c2c5c5bdfac13b4f48e8cf05839cda2b4c30419cf2a53e60304be9"
    }
  },
  {
    "ts": null,
    "headline": "Dow 30 December Dogs Show 28 Pay Dividends And 1 \"Safer\" Buy",
    "summary": "While most of this collection of Dow Industrials is too pricey and reveals only skinny dividends, one of the ten lowest priced Dogs of the Dow is ready to buy. Read on to find out which one.",
    "url": "https://finnhub.io/api/news?id=15e66617820a3c8667c0dac86e09c763de246865d1f7e9d08e9f312422bbb1d6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733333838,
      "headline": "Dow 30 December Dogs Show 28 Pay Dividends And 1 \"Safer\" Buy",
      "id": 131770508,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/149130950/image_149130950.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "While most of this collection of Dow Industrials is too pricey and reveals only skinny dividends, one of the ten lowest priced Dogs of the Dow is ready to buy. Read on to find out which one.",
      "url": "https://finnhub.io/api/news?id=15e66617820a3c8667c0dac86e09c763de246865d1f7e9d08e9f312422bbb1d6"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
    "summary": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=1f796e1326332731b72a6e0a986d046b4859bebbc5da1d351b5e94a3e3047a57",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733329860,
      "headline": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
      "id": 131775377,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=1f796e1326332731b72a6e0a986d046b4859bebbc5da1d351b5e94a3e3047a57"
    }
  },
  {
    "ts": null,
    "headline": "Why Is Johnson & Johnson (JNJ) Among the Dividend Kings You Should Consider?",
    "summary": "We recently compiled a list of the Dividend Kings List: Top 15. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other dividend kings you should know about. Dividend Kings are a distinguished group of companies that have achieved at least 50 consecutive years of dividend […]",
    "url": "https://finnhub.io/api/news?id=dde391571e592aedcd92868423a9c465071404f2bebc4cc8027a2ed6bca450ba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733317507,
      "headline": "Why Is Johnson & Johnson (JNJ) Among the Dividend Kings You Should Consider?",
      "id": 131768826,
      "image": "https://s.yimg.com/ny/api/res/1.2/DBFyZ0OZ_JyFkP8R8eQoiQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/f9ccf3c88c7274582ef19e20143427c2",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the Dividend Kings List: Top 15. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other dividend kings you should know about. Dividend Kings are a distinguished group of companies that have achieved at least 50 consecutive years of dividend […]",
      "url": "https://finnhub.io/api/news?id=dde391571e592aedcd92868423a9c465071404f2bebc4cc8027a2ed6bca450ba"
    }
  },
  {
    "ts": null,
    "headline": "The big rebrand: Why these 4 biopharmas changed their name this year",
    "summary": "Four companies that refreshed their mission and public persona with a new look.",
    "url": "https://finnhub.io/api/news?id=d30518c6666fd5684e38af3d7228647bf4a6f061b71a9bfa0cdca8849bb9ee8c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733299200,
      "headline": "The big rebrand: Why these 4 biopharmas changed their name this year",
      "id": 131768827,
      "image": "https://imgproxy.divecdn.com/zEBtkDOon1N2DkL4CHs1frlAPCQailigNwXXuws7dGs/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xODY3NzA1MDUuanBn.webp",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Four companies that refreshed their mission and public persona with a new look.",
      "url": "https://finnhub.io/api/news?id=d30518c6666fd5684e38af3d7228647bf4a6f061b71a9bfa0cdca8849bb9ee8c"
    }
  }
]